[{"address1": "175 Innovation Boulevard", "city": "Wilmington", "state": "DE", "zip": "19805", "country": "United States", "phone": "302 467 1280", "website": "https://preludetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Krishna  Vaddi D.V.M., Ph.D.", "age": 59, "title": "Founder, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 881092, "exercisedValue": 0, "unexercisedValue": 12515}, {"maxAge": 1, "name": "Mr. Bryant David Lim J.D.", "age": 54, "title": "CFO, Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 621017, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Aimee  Crombie Ph.D.", "title": "Senior VP and Head of Strategic Planning & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Madhu  Pudipeddi Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peggy A. Scherle Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 868617, "exercisedValue": 0, "unexercisedValue": 436567}, {"maxAge": 1, "name": "Mr. Robert A. Doody Jr.", "title": "Senior Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Porreca M.B.A.", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew P. Combs Ph.D.", "age": 58, "title": "Executive VP & Chief Chemistry Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 562461, "exercisedValue": 0, "unexercisedValue": 399432}, {"maxAge": 1, "name": "Mr. Naveen  Babbar Ph.D.", "title": "Senior Vice President of Translation Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wan-Jen  Hong M.D.", "age": 46, "title": "Senior Vice President of Clinical Development", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.21, "open": 2.2, "dayLow": 1.995, "dayHigh": 2.21, "regularMarketPreviousClose": 2.21, "regularMarketOpen": 2.2, "regularMarketDayLow": 1.995, "regularMarketDayHigh": 2.21, "payoutRatio": 0.0, "beta": 0.888, "forwardPE": -1.7641921, "volume": 213776, "regularMarketVolume": 213776, "averageVolume": 1535165, "averageVolume10days": 595080, "averageDailyVolume10Day": 595080, "bid": 1.97, "ask": 2.06, "bidSize": 4, "askSize": 4, "marketCap": 126987848, "fiftyTwoWeekLow": 0.61, "fiftyTwoWeekHigh": 4.22, "allTimeHigh": 95.375, "allTimeLow": 0.61, "priceToSalesTrailing12Months": 12.094081, "fiftyDayAverage": 1.9627, "twoHundredDayAverage": 1.2837, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 129339864, "profitMargins": 0.0, "floatShares": 16400390, "sharesOutstanding": 43765011, "sharesShort": 1472870, "sharesShortPriorMonth": 995838, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0234, "heldPercentInsiders": 0.09934, "heldPercentInstitutions": 0.54477, "shortRatio": 3.09, "shortPercentOfFloat": 0.19549999, "impliedSharesOutstanding": 62865270, "bookValue": 0.769, "priceToBook": 2.6267881, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -111772000, "trailingEps": -1.47, "forwardEps": -1.145, "enterpriseToRevenue": 12.318, "enterpriseToEbitda": -1.084, "52WeekChange": 0.78761065, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 2.02, "targetHighPrice": 5.0, "targetLowPrice": 3.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 54957000, "totalCashPerShare": 0.667, "ebitda": -119267000, "totalDebt": 17854000, "quickRatio": 3.021, "currentRatio": 3.207, "totalRevenue": 10500000, "debtToEquity": 30.502, "revenuePerShare": 0.138, "returnOnAssets": -0.51823, "returnOnEquity": -1.03991, "grossProfits": 10500000, "freeCashflow": -64799624, "operatingCashflow": -100165000, "revenueGrowth": 1.167, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -3.1412299, "financialCurrency": "USD", "symbol": "PRLD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601040600000, "postMarketChangePercent": 3.9603922, "postMarketPrice": 2.1, "postMarketChange": 0.07999992, "regularMarketChange": -0.19, "regularMarketDayRange": "1.995 - 2.21", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1535165, "fiftyTwoWeekLowChange": 1.41, "fiftyTwoWeekLowChangePercent": 2.3114753, "fiftyTwoWeekRange": "0.61 - 4.22", "fiftyTwoWeekHighChange": -2.1999998, "fiftyTwoWeekHighChangePercent": -0.521327, "fiftyTwoWeekChangePercent": 78.76106, "earningsTimestamp": 1762954200, "earningsTimestampStart": 1762954200, "earningsTimestampEnd": 1762954200, "earningsCallTimestampStart": 1762952400, "earningsCallTimestampEnd": 1762952400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.47, "epsForward": -1.145, "epsCurrentYear": -1.27, "priceEpsCurrentYear": -1.5905511, "shortName": "Prelude Therapeutics Incorporat", "longName": "Prelude Therapeutics Incorporated", "fiftyDayAverageChange": 0.05729997, "fiftyDayAverageChangePercent": 0.029194463, "twoHundredDayAverageChange": 0.7363, "twoHundredDayAverageChangePercent": 0.5735764, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-25", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1769212007, "regularMarketTime": 1769202000, "exchange": "NMS", "messageBoardId": "finmb_373775974", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -8.59729, "regularMarketPrice": 2.02, "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]